총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Oncternal Therapeutics, Inc. (ONCT), 포함 34 건 매수 및 16 건 매도. 내부자 매수 총액은 $1.01M 내부자 매도 총액은 $1.35M.
최근 활동이 있는 주요 내부자에는 Hale David F, Kisner Daniel L, Larue William R. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — ONCT
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2024-06-20 |
Hale David F |
Director |
RSU 부여 |
3,300 |
$8.10 |
$26.73K |
3,300 |
| 2024-06-20 |
Kisner Daniel L |
Director |
RSU 부여 |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Larue William R |
Director |
RSU 부여 |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Carter Michael G |
Director |
RSU 부여 |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Mazanet Rosemary |
Director |
RSU 부여 |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Theuer Charles |
Director |
RSU 부여 |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Wills Robert James |
Director |
RSU 부여 |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Desimone Jill |
Director |
RSU 부여 |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-04-08 |
Wills Robert James |
Director |
정보 매수 |
3,086 |
$8.96 |
$27.65K |
10,000 |
| 2024-03-28 |
Wills Robert James |
Director |
정보 매수 |
6,914 |
$8.48 |
$58.6K |
6,914 |
| 2024-02-23 |
Hale David F |
Director |
정보 매수 |
714 |
$9.04 |
$6.45K |
714 |
| 2024-02-23 |
Wills Robert James |
Director |
정보 매도 |
980 |
$9.04 |
$8.86K |
- |
| 2024-02-14 |
Breitmeyer James B |
Chief Executive Officer |
RSU 부여 |
6,200 |
$9.18 |
$56.92K |
6,200 |
| 2024-02-14 |
Vincent Richard G |
Chief Financial Officer |
RSU 부여 |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Leavitt Chase C. |
General Counsel/secretary |
RSU 부여 |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Yazji Salim |
Chief Medical Officer |
RSU 부여 |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Krishnan Rajesh |
CTO/cso |
RSU 부여 |
17,700 |
$9.18 |
$162.49K |
17,700 |
| 2024-01-03 |
Breitmeyer James B |
Chief Executive Officer |
RSU 원천징수 |
4,485 |
$0.50 |
$2.23K |
15,426 |
| 2024-01-03 |
Vincent Richard G |
Chief Financial Officer |
RSU 원천징수 |
8,868 |
$0.50 |
$4.4K |
140,922 |
| 2024-01-03 |
Leavitt Chase C. |
General Counsel/secretary |
RSU 원천징수 |
11,838 |
$0.50 |
$5.87K |
84,758 |
| 2024-01-03 |
Yazji Salim |
Chief Medical Officer |
RSU 원천징수 |
19,742 |
$0.50 |
$9.79K |
128,635 |
| 2024-01-03 |
Krishnan Rajesh |
Chief Technical Officer |
RSU 원천징수 |
11,838 |
$0.50 |
$5.87K |
44,019 |
| 2023-10-02 |
Breitmeyer James B |
Chief Executive Officer |
주식 반환 |
100,000 |
$5.76 |
$576K |
- |
| 2023-10-02 |
Vincent Richard G |
Chief Financial Officer |
주식 반환 |
210,000 |
$0.96 |
$201.6K |
- |
| 2023-10-02 |
Leavitt Chase C. |
General Counsel/secretary |
주식 반환 |
55,519 |
$1.94 |
$107.71K |
- |
| 2023-10-02 |
Yazji Salim |
Chief Medical Officer |
주식 반환 |
210,000 |
$0.96 |
$201.6K |
- |
| 2023-10-02 |
Krishnan Rajesh |
Chief Technical Officer |
주식 반환 |
220,000 |
$0.96 |
$211.2K |
- |
| 2023-07-03 |
Breitmeyer James B |
Chief Executive Officer |
RSU 원천징수 |
4,007 |
$0.36 |
$1.44K |
19,911 |
| 2023-07-03 |
Vincent Richard G |
Chief Financial Officer |
RSU 원천징수 |
7,069 |
$0.36 |
$2.54K |
149,790 |
| 2023-07-03 |
Leavitt Chase C. |
General Counsel/secretary |
RSU 원천징수 |
10,305 |
$0.36 |
$3.71K |
96,596 |
| 2023-07-03 |
Yazji Salim |
Chief Medical Officer |
RSU 원천징수 |
16,299 |
$0.36 |
$5.87K |
148,377 |
| 2023-07-03 |
Krishnan Rajesh |
Chief Technology Officer |
RSU 원천징수 |
10,897 |
$0.36 |
$3.92K |
55,857 |
| 2023-06-28 |
Hale David F |
Director |
RSU 부여 |
37,500 |
$0.36 |
$13.32K |
37,500 |
| 2023-06-28 |
Kisner Daniel L |
Director |
RSU 부여 |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Larue William R |
Director |
RSU 부여 |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Carter Michael G |
Director |
RSU 부여 |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Mazanet Rosemary |
Director |
RSU 부여 |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Theuer Charles |
Director |
RSU 부여 |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Wills Robert James |
Director |
RSU 부여 |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Nakanishi Xin |
Director |
RSU 부여 |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Desimone Jill |
Director |
RSU 부여 |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-14 |
Kaufmann Gunnar F. |
Chief Scientific Officer |
정보 매수 |
3,000 |
$0.36 |
$1.08K |
94,726 |
| 2023-06-12 |
Kaufmann Gunnar F. |
Chief Scientific Officer |
정보 매수 |
25,000 |
$0.35 |
$8.75K |
91,726 |
| 2023-04-14 |
Yazji Salim |
Chief Medical Officer |
정보 매수 |
5,000 |
$0.30 |
$1.5K |
164,676 |
| 2023-04-14 |
Breitmeyer James B |
Chief Executive Officer |
정보 매수 |
47,750 |
$0.30 |
$14.28K |
194,294 |
| 2023-04-13 |
Vincent Richard G |
Chief Financial Officer |
정보 매수 |
30,000 |
$0.30 |
$8.96K |
156,859 |
| 2023-04-13 |
Leavitt Chase C. |
General Counsel/secretary |
정보 매수 |
10,000 |
$0.29 |
$2.9K |
106,901 |
| 2023-04-13 |
Yazji Salim |
Chief Medical Officer |
정보 매수 |
10,000 |
$0.29 |
$2.85K |
159,676 |
| 2023-04-13 |
Breitmeyer James B |
Chief Executive Officer |
정보 매수 |
100,000 |
$0.29 |
$29K |
146,544 |
| 2023-04-12 |
Leavitt Chase C. |
General Counsel/secretary |
정보 매수 |
15,000 |
$0.29 |
$4.35K |
96,901 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
